Summer Sale

Up to 30% off — ends 7 Aug

ONLY00h00m00s

Get 30% Off

Up to 30% off — ends 7 Aug

ONLY00h00m00s

William Paxton

Professor

University of Liverpool

United Kingdom

This profile is automatically generated from trusted academic sources.

Google Scholar

ORCID

How do I reach out?

Meet Kite AI

Contact this professor

ORCID

Google Scholar

Research Interests

Virology

40%

Epidemiology

20%

Covid-19

60%

Sars-cov-2

40%

Hiv/aids Research

20%

Inflammatory Biology

20%

Clinical Risk

20%

Ask ApplyKite AI

Start chatting

How can you help me contact this professor?

What are this professor's research interests?

How should I write an email to this professor?

Articles10

Fitting to the UK COVID-19 outbreak, short-term forecasts and estimating the reproductive number

Article Link

Year:

2022

Implementation of corticosteroids in treatment of COVID-19 in the ISARIC WHO Clinical Characterisation Protocol UK: prospective, cohort study

Article Link

Year:

2022

SARS-CoV-2 Omicron-B.1.1.529 leads to widespread escape from neutralizing antibody responses

Article Link

Year:

2022

Mapping of SARS-CoV-2 IgM and IgG in gingival crevicular fluid: Antibody dynamics and linkage to severity of COVID-19 in hospital inpatients

Article Link

Year:

2022

The HCV Envelope Glycoprotein Down-Modulates NF-κB Signalling and Associates With Stimulation of the Host Endoplasmic Reticulum Stress Pathway

Article Link

Year:

2022

Measuring Proviral HIV-1 DNA: Hurdles and Improvements to an Assay Monitoring Integration Events Utilising Human Alu Repeat Sequences

Article Link

Year:

2021

Risk of adverse outcomes in patients with underlying respiratory conditions admitted to hospital with COVID-19: a national, multicentre prospective cohort study using the ISARIC WHO Clinical Characterisation Protocol UK.

Article Link

Year:

2021

Risk of adverse outcomes in patients with underlying respiratory conditions admitted to hospital with COVID-19: a national, multicentre prospective cohort study using the ISARIC WHO Clinical Characterisation Protocol UK

Article Link

Year:

2021

Inflammatory profiles across the spectrum of disease reveal a distinct role for GM-CSF in severe COVID-19.

Article Link

Year:

2021

Generation of Liposomes to Study the Effect of Mycobacterium Tuberculosis Lipids on HIV-1 cis- and trans-Infections.

Article Link

Year:

2021

Collaborators20

Laurence McEvoy

University of Liverpool

UNITED KINGDOM

Gurdyal Besra

University of Birmingham

UNITED KINGDOM

Antonia Ho

Clinical Senior Lecturer

MRC-University of Glasgow Centre For Virus Research

UNITED KINGDOM

Stuart Hartshorn

Honorary Assistant Professor

University of Birmingham

UNITED KINGDOM

Matthew Siggins

Imperial College London

UNITED KINGDOM

Petros Andrikopoulos

Assistant Professor, MRC Career Development Fellow

Imperial College London

UNITED KINGDOM

Alessandra Ruggiero

Junior Researcher - Junior Assistant Profession

University of Verona

ITALY

Anna Maria Geretti

University of Rome Tor Vergata

ITALY

Susan Shenkin

Karolinska Institutet

SWEDEN

Ward De Spiegelaere

Associate Professor

Ghent University

BELGIUM

Edward Hill

Warwick Zeeman Lecturer

University of Warwick

UNITED KINGDOM

Louise Dyson

University of Warwick

UNITED KINGDOM

Marc Dieu

University of Namur

BELGIUM

Wei Shen Lim

Consultant Respiratory Physician and Honorary Professor

Nottingham University Hospitals NHS Trust

UNITED KINGDOM

Chang Liu

University of Oxford

UNITED KINGDOM

David Koeckerling

University Hospital Heidelberg

GERMANY

Jingshan Ren

University of Oxford

UNITED KINGDOM

Gary Leeming

University of Liverpool

UNITED KINGDOM

Samreen Ijaz

Head, Blood Borne Virus Unit

Public Health England Colindale

UNITED KINGDOM

Daniel Jenkin

University of Oxford

UNITED KINGDOM

How do I reach out?

Meet Kite AI

William Paxton

Professor

How do I reach out?

Contact this professor

Research Interests

Ask ApplyKite AI

Articles10

Fitting to the UK COVID-19 outbreak, short-term forecasts and estimating the reproductive number

Implementation of corticosteroids in treatment of COVID-19 in the ISARIC WHO Clinical Characterisation Protocol UK: prospective, cohort study

SARS-CoV-2 Omicron-B.1.1.529 leads to widespread escape from neutralizing antibody responses

Mapping of SARS-CoV-2 IgM and IgG in gingival crevicular fluid: Antibody dynamics and linkage to severity of COVID-19 in hospital inpatients

The HCV Envelope Glycoprotein Down-Modulates NF-κB Signalling and Associates With Stimulation of the Host Endoplasmic Reticulum Stress Pathway

Measuring Proviral HIV-1 DNA: Hurdles and Improvements to an Assay Monitoring Integration Events Utilising Human Alu Repeat Sequences

Risk of adverse outcomes in patients with underlying respiratory conditions admitted to hospital with COVID-19: a national, multicentre prospective cohort study using the ISARIC WHO Clinical Characterisation Protocol UK.

Risk of adverse outcomes in patients with underlying respiratory conditions admitted to hospital with COVID-19: a national, multicentre prospective cohort study using the ISARIC WHO Clinical Characterisation Protocol UK

Inflammatory profiles across the spectrum of disease reveal a distinct role for GM-CSF in severe COVID-19.

Generation of Liposomes to Study the Effect of <i>Mycobacterium Tuberculosis</i> Lipids on HIV-1 <i>cis</i>- and <i>trans</i>-Infections.

Collaborators20

Laurence McEvoy

Gurdyal Besra

Antonia Ho

Stuart Hartshorn

Matthew Siggins

Petros Andrikopoulos

Alessandra Ruggiero

Anna Maria Geretti

Susan Shenkin

Ward De Spiegelaere

Edward Hill

Louise Dyson

Marc Dieu

Wei Shen Lim

Chang Liu

David Koeckerling

Jingshan Ren

Gary Leeming

Samreen Ijaz

Daniel Jenkin

How do I reach out?